BRCA1 and cancer: The sister of PN3 (p.D1778Gfs*27 heterozygote) had breast/ovarian cancers at around 10 years older than the age PN3 developed cancer, possibly suggesting a worsened HBOC (BRCA1) phenotype due to compound heterozygosity.